Manager/Sr Manager, Scientific Communications and Publications

About QED Therapeutics & BridgeBio Pharma

QED Therapeutics, an affiliate of BridgeBio Pharma, focuses on developing targeted treatments for FGFR-driven skeletal dysplasias, particularly Achondroplasia. Achondroplasia is the most common form of genetically-driven short stature, which causes potentially debilitating medical complications. With our experimental therapeutic candidate, infigratinib, we seek to provide an option to children living with Achondroplasia and their families.
 
Our business is inspired by our values:

• PUT PATIENTS FIRST
• LET SCIENCE SPEAK
• EVERY MINUTE COUNTS
• THINK INDEPENDENTLY
• BE RADICALLY TRANSPARENT

FGFR=fibroblast growth factor receptor.

BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 30+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs.

Our focus on scientific excellence and rapid execution aims to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, Raleigh, and with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zug, Switzerland, and are expanding across Europe.

To learn more about our story and company culture, visit us at https://www.qedtx.com/ | https://bridgebio.com 

Who You Are

The role of the Manager/Sr Manager, Scientific Communications and Publications involves providing medical writing and operational support to the Scientific Communications and Publication Strategy team within Medical Affairs. This position will report to the Senior Director of Scientific Communications and Publication Strategy. Key areas of focus will be to assist in the development and implementation of scientific communication and publication plans for BridgeBio/QED in alignment with business objectives.   

Responsibilities

• Contribute to content development of a diverse range of deliverables within medical publications and scientific communications, including writing and editing high-quality medical journal articles, conference abstracts, poster presentations, slide deck presentations, and white papers  
• Contribute to publication and communication plans 
• Support publication activities including collecting author agreements and financial disclosures, overseeing the publication review process, and managing abstract and conference submissions 
• Create and maintain accurate and complete records …